论文部分内容阅读
脑血管疾病是有劳动能力年龄者残废的常见原因之一。其中以脑血栓更为多见,此类病人常有血液凝固性过高和抗凝系统机能低下的特点,易于复发。考虑到缺血性脑卒中(脑血栓形成)发病机制的这一特点,为预防血栓的再次形成,近20年来,人们多将抗凝剂内服给药,但使用这些制剂常发生出血性合并症,因而难于确定一种合适的剂量,同时血液凝固和抗凝系统主要参数波动较大,所以必须选择一些能使抗凝剂缓慢而长期地进入机体的方法。药物离子导入法就可以满足这些要求。应用物理因子(尤其是药物离子导入)作用于血液凝固和抗凝系统,可以避免口服
Cerebrovascular disease is one of the common causes of disability in people with a working capacity. Among them, cerebral thrombosis is more common, such patients often have high blood coagulation and anticoagulant system dysfunction, easy to relapse. Considering this characteristic of the pathogenesis of ischemic stroke (cerebral thrombosis), anticoagulants are mostly administered orally in order to prevent the re-formation of thrombus in the past 20 years, but hemorrhagic complications often occur when using these preparations , So it is difficult to determine a suitable dose, while the main parameters of the blood coagulation and anticoagulation system fluctuations, it must choose some of the anticoagulant can be slow and long-term access to the body. Drug iontophoresis to meet these requirements. The use of physical factors (especially drug iontophoresis) on the blood coagulation and anticoagulation system can be avoided orally